Amy Calistri
Stock of the Month
Stephen Leeb
Income Performance Report
Roger Conrad
The Utility Forecaster
Paul McWilliams
Next Inning

'Elite' look at Almost Family (AFAM)


Bookmark and Share

 "Almost Family (NASDAQ: AFAM) is making its triumphant return to our 'focus list'of buys after we sold it in January," says analyst Tracey Ryniec. Here's her latest in Zacks Elite Stocks.

"AFAM provides home health nursing, rehabilitation and personal care services in 11 states. The company has two segments: Visiting Nurse (VN) and Personal Care (PC).

"Visiting Nurse provides skilled nursing and physical, occupational and speech therapy. Personal Care includes custodial and personal care services.

Advertisement
Banner

"The company's acquisition strategy continues with the May 27 announcement that it was acquiring the assets of Florida-based Central Florida Health Alliance (CHFA), a two-hospital health care system with home health branches.

"CHFA's operations generated $4.5 million in revenue in the last fiscal year, but Almost Family doesn't expect it to have a material impact on its 2009 results. The terms of the deal were not disclosed.

"The company continues to post strong earnings results despite the economic slowdown. On May 6, Almost Family surprised on estimates for the 6th straight quarter by 13.33%.

"Net income rose 118% to $5.6 million, or 68 cents per share, compared with $2.5 million, or 44 cents, in the year ago period. 

"Revenue surged 77% to $69.2 million. The Visiting Nurse segment saw big gains, jumping 97% compared to a year ago with 41% of that coming from organic growth and the rest from acquired operations. Personal Care segment revenue gained 14%.

"Consensus estimates are rising for the second quarter and 2009. Second quarter estimates rose 3 cents to 67 cents in the last month.

"2009 consensus estimates jumped nearly 6% to $2.74 from $2.59 per share in the last 30 days, with 5 out of 6 covering analysts raising including one in the last week. Analysts expect year over year earnings growth of 26.04%.

"Overall, in our view, the stock has solid fundamentals. Almost Family is a Zacks #1 Rank (strong buy) stock. It is attractively valued with a forward P/E of just 9.5. The company has an outstanding 1-year return on equity of 21.03%."


Banner
News Flash

Linkedin: Professional profits
by Leo Fasciocco, editor Ticker Tape Digest

Online professional network operator Linkedin (LNKD) recently moved above its technical breakout point of $108.53. We now target a move to $138.


Read more...

 

Tap in to water stocks
by Doug Fabian, editor Making Money Alert

As we prepare for the summer heat, water presents a significant investment opportunity -- especially as states such as California and Texas face droughts. The PowerShares Water Resource ETF (PHO) presents one way to invest in water's untapped potential.


Read more...


   

Pax World: High yield exception
by Amy Calistri, editor The Daily Paycheck

I generally prefer closed-end or exchange-traded funds because the fees tend to be lower. But I made a special case for Pax World High Yield Bond (PAXHX); this high-yield bond fund is my only open-ended mutual fund holding.


Read more...

 

Amgen: Biotech DRIP
by Chuck Carlson, editor DRIP Investor

Amgen (AMGN) is one of the oldest and largest players in the biotechnology area. It pioneered the development of products based on advances in recombinant DNA and molecular biology, launching the biotechnology industry’s first blockbuster medicines.


Read more...

 

Fidelity fund expert looks to Japan
by Jim Lowell, editor Fidelity Investor

In my May Marketwatch investment strategy column I noted, “Set against the backdrop of having already been thrown out with the Eurozone’s bathwater, I like Japan’s marketplace overall and, more specifically, their small cap marketplace which caters to domestic counter traffic.”


Read more...

 

MOO: Market Vectors Agribusiness
by Doug Fabian, editor Making Money Alert

Everyone needs food to survive, so wouldn't it be great to make money from it? We can. The global agriculture business provides a fairly stable investment with growth potential. In particular, I am looking at Market Vectors Agribusiness ETF (MOO).


Read more...

 

Celgene: Selloff creates opportunity
by J. Royden Ward, editor Cabot Benjamin Graham Value Letter

Celgene (CELG) develops and assists in the marketing of drugs to treat cancer and infl ammatory diseases. It acquired several companies recently, which will expand its product line and add promising products in various stages of development.


Read more...

 

Senior housing reits for income
by Brian Hicks, editor Wealth Advisory

Omega Healthcare Investors (OHI) and Medical Properties Trust (MPW) caters to the senior housing/assisted living facilities. Given the growing senior population, it makes sense to be somewhat over-exposed to companies that target this market.


Read more...

 

Buffett: Still banking on banks
by Ron Rowland, editor All Star Investor

Wise investors zero in on conflicting data points. Warren Buffett, the wisest investor of all, provided plenty to consider at the Berkshire Hathaway annual meeting. 


Read more...

 

Questcor: 'Exponential demand'
by Dennis Slothower, editor Stealth Stocks

Questcor Pharmaceuticals (QCOR), our latest featured stock of the month, is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary